Herantis Pharma PLC (OTCPK:HRPMF)
$ 3.51 0 (0%) Market Cap: 29.91 Mil Enterprise Value: 29.51 Mil PE Ratio: 0 PB Ratio: 14.11 GF Score: 37/100

Q4 2021 Herantis Pharma Oyj Earnings Call Transcript

Mar 03, 2022 / 08:00AM GMT
Release Date Price: $3.51
Julie Silber
Herantis Pharma Oyj - IR

Good morning and welcome to the Herantis Pharma second half of 2021 live webinar. My name is Julie Silber, and I will be your moderator for today's event.

Presenting today will be interim CEO Frans Wuite. The next slide, if you can click forward, shows our disclosure statement. As a quick reminder to listeners during today's webinar, management may make forward-looking statements involving known and unknown risks, uncertainties and other important factors beyond the company's control that could cause the company's actual results, performance, or achievements to be materially different from the expected results, performance, or achievements expressed or implied by such forward-looking statements. Please note that the forward-looking statements made during this webinar speak only as of today's date, and the company undertakes no obligation to update them to reflect subsequent events or circumstances other than to the extent required by law.

Today, the company will give a brief update, and then we'll conclude with a Q&A session. (Conference

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot